Mephenesin

Mephenesin

Systematic (IUPAC) name
3-(2-methylphenoxy)propane-1,2-diol
Clinical data
AHFS/Drugs.com	International Drug Names
Legal status	?
Identifiers
CAS number	59-47-2 N
ATC code	M03BX06
PubChem	CID 4059
ChemSpider	3919 Y
UNII	7B8PIR2954 Y
KEGG	D02595 Y
ChEMBL	CHEMBL229128 Y
NIAID ChemDB	017830
Chemical data
Formula	C10H14O3
Mol. mass	182.216 g/mol
SMILES O(c1ccccc1C)CC(O)CO
InChI InChI=1S/C10H14O3/c1-8-4-2-3-5-10(8)13-7-9(12)6-11/h2-5,9,11-12H,6-7H2,1H3 Y Key:JWDYCNIAQWPBHD-UHFFFAOYSA-N Y
N (what is this?)  (verify)

Mephenesin is a centrally acting muscle relaxant. It can be used as an antidote for strychnine poisoning. Mephenesin however presents with the major drawbacks of having a short duration of action and a much greater effect on the spinal cord than the brain, resulting in pronounced respiratory depression at clinical doses and therefor a very low therapeutic index. Mephenesin was used by Dr. Bernard Ludwig and Dr. Frank Milan Berger to synthesize meprobamate, the first tranquilizer to see widespread clinical use. Mephenesin is no longer available in North America but is used in France, Italy and a few other countries.^[1] Its use has largely been replaced by the related drug methocarbamol, which is better absorbed^[2]

See also

• Chlorphenesin
• Mephenoxalone
• Methocarbamol

External links

• Bachmeyer C, Blum L, Fléchet M, Duriez P, Cabane J, Imbert J (1996). "[Severe contact dermatitis caused by mephenesin]". Ann Dermatol Venereol 123 (3): 185–7. PMID 8761781. 
• Ono H, Nakamura T, Ito H, Oka J, Fukuda H (1987). "Rigidity in rats due to radio frequency decerebration and effects of chlorpromazine and mephenesin". Gen Pharmacol 18 (1): 57–9. PMID 3557053. 

References